Empower Advisory Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Empower Advisory Group's HALO Position: Q2 2026 in Review
Empower Advisory Group reduced its Halozyme (HALO) stake by 3.2% in Q2 2026, selling an estimated $7.16K and leaving 3,205 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #470.
Empower Advisory Group first reported a position in HALO in Q1 2023 and has held it in 14 quarters since. The position peaked at $553K in Q4 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Empower Advisory Group held 3,205 shares of Halozyme worth $251K as of Q2 2026.
- Empower Advisory Group sold 105 Halozyme shares in Q2 2026, an estimated $7.16K.
- Halozyme made up ﹤0.01% of Empower Advisory Group's portfolio in Q2 2026, its #470 holding.
- Empower Advisory Group first reported a position in Halozyme in Q1 2023 and has held it in 14 quarters since.
- Empower Advisory Group's Halozyme position peaked at $553K in Q4 2025.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.